Hypoplastic Left Heart Syndrome

The Lynch Lab's primary focus is on the development and use of novel biomedical optical tools to study risk for neurologic injury in children with cardiac diseases.

The purpose of this research study is to learn more about improving the treatment and outcomes for patients who have a diagnosis of a single ventricle, such as Hypoplastic Left Heart Syndrome (HLHS) or similar heart defects.

The purpose of this research study is to find out if stem cells from umbilical cord blood can strengthen the muscle of the right side of the heart for patients diagnosed with Hypolplastic Left Heart Syndrome who are scheduled to undergo the Stage II Glenn surgical procedure.

Conducting a group of dynamic research projects for families affected by hypoplastic left heart syndrome, including research involving the use of autologous stem cells (from the patient’s own body) derived from umbilical cord blood collected at birth.